Si-Bone (SIBN) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -236.69% |
| Dec 31, 2025 | -26.00% |
| Sep 30, 2025 | 1,249.71% |
| Jun 30, 2025 | 103.52% |
| Mar 31, 2025 | -516.89% |
| Dec 31, 2024 | 290.07% |
| Sep 30, 2024 | 104.77% |
| Jun 30, 2024 | 16.34% |
| Mar 31, 2024 | -229.60% |
| Dec 31, 2023 | -10.81% |
| Sep 30, 2023 | 42.26% |
| Jun 30, 2023 | 66.61% |
| Mar 31, 2023 | -58.72% |
| Dec 31, 2022 | -3.80% |
| Sep 30, 2022 | 56.02% |
| Jun 30, 2022 | -9.84% |
| Mar 31, 2022 | -6.28% |
| Dec 31, 2021 | -36.58% |
| Sep 30, 2021 | -14.21% |
| Jun 30, 2021 | 12.91% |
| Mar 31, 2021 | -18.74% |
| Dec 31, 2020 | -41.97% |
| Sep 30, 2020 | 29.48% |
| Jun 30, 2020 | 15.84% |
| Mar 31, 2020 | -3.56% |
| Dec 31, 2019 | -26.87% |
| Sep 30, 2019 | 15.20% |
| Jun 30, 2019 | -18.62% |
| Mar 31, 2019 | -12.05% |
| Dec 31, 2018 | -149.78% |
| Sep 30, 2018 | -100.40% |
| Jun 30, 2018 | 71.39% |
| Mar 31, 2018 | -9.29% |